Ovarian Carcinoma Clinical Trials

162 clinical trials for Ovarian Carcinoma across international registries, including 43 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• The Vanguard Study: Testing a New Way to Screen for Cancer — RECRUITING · NA
• A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer — RECRUITING · NA
• Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors — RECRUITING
• A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE2
• A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer — RECRUITING · NA
• Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer — RECRUITING · PHASE3
• IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence — RECRUITING · PHASE2
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas — RECRUITING · PHASE2
• A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) — RECRUITING · NA
• Real-World Outcomes of minimally invasive versus open surgery in early-stage ovarian and borderline tumors, ROMIO-trial — RECRUITING
• Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer — RECRUITING · NA
• Adapted Helping Ovarian Cancer Patients Cope Intervention to Address Burnout for Gynecologic Oncology Clinicians — RECRUITING · NA
• Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer — RECRUITING · PHASE1
• Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing — RECRUITING
• A Study of Intra-operative Imaging in Women With Ovarian Cancer — RECRUITING · PHASE3
• A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products — RECRUITING
• A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours — RECRUITING · PHASE1
• Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors — RECRUITING · PHASE1
• Prospective Study of Immune Alterations in Operable Breast and Ovarian Carcinoma — RECRUITING
• DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer — RECRUITING · PHASE1
• A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors — RECRUITING · PHASE1
• Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study — RECRUITING
• Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF — RECRUITING · PHASE1
• Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery — RECRUITING · PHASE2
• Access to Genetic Testing in Underserved Patients With Cancer — RECRUITING · NA
• Expression VIII - Individual perception and level of information of patients with a low-grade ovarian carcinoma or a borderline tumor of the ovary — RECRUITING
• Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy — RECRUITING · NA
• Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2 — RECRUITING
• Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions — RECRUITING · NA
• A First-in-Human, JAB-8263 in Adult Patients With Advanced Tumors — RECRUITING · PHASE1
• OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study — RECRUITING · NA
• NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer — RECRUITING · PHASE1
• Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin — RECRUITING · PHASE2
• Benefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer: — RECRUITING · PHASE3
• Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers — RECRUITING · PHASE2
• Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer — RECRUITING · PHASE1
• Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy — RECRUITING
• Niraparib Versus Bevacizumab as Maintenance Therapy in Patients With de Novo Ovarian Cancer Without Homologous Recombination Deficiency — RECRUITING
• Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer — RECRUITING · NA
• RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression — RECRUITING · PHASE2
• Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies — RECRUITING
• ATR INHIBITOR IN COMBINATION WITH OLAPARIB/ DURVALUMAB (MEDI4736) IN GYNAECOLOGICAL CANCERS WITH ARID1A LOSS OR NO LOSS — RECRUITING
• A RANDOMIZED PHASE III, TWO-ARM TRIAL OF PACLITAXEL/CARBOPLATIN/MAINTENANCE LETROZOLE VERSUS LETROZOLE MONOTHERAPY IN PATIENTS WITH STAGE II-IV, PRIMARY LOW-GRADE SEROUS CARCINOMA OF THE OVARY OR PERITONEUM — RECRUITING · PHASE3
• A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations — ACTIVE_NOT_RECRUITING · PHASE1
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) — ACTIVE_NOT_RECRUITING · PHASE2
• Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction — ACTIVE_NOT_RECRUITING · PHASE1
• Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial) — ACTIVE_NOT_RECRUITING · NA
• Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer — COMPLETED · PHASE2
• Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers — ACTIVE_NOT_RECRUITING · PHASE1

Refine this search